Assets in USD of Regencell Bioscience Holdings Ltd from Q2 2020 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Regencell Bioscience Holdings Ltd quarterly Assets history and growth rate from Q2 2020 to Q2 2025.
Regencell Bioscience Holdings Ltd Assets for the quarter ending June 30, 2025 was $5.76M, a 31.8% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Regencell Bioscience Holdings Ltd Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$5.76M	-$2.68M	-31.8%	Jun 30, 2025	20-F	2025-10-31
Q2 2024	$8.44M	-$4.18M	-33.1%	Jun 30, 2024	20-F	2025-10-31
Q2 2023	$12.6M	-$5.4M	-30%	Jun 30, 2023	20-F	2024-10-25
Q2 2022	$18M	+$17.7M	+5198%	Jun 30, 2022	20-F	2023-10-27
Q2 2021	$340K	-$174K	-33.8%	Jun 30, 2021	20-F	2022-10-31
Q2 2020	$514K			Jun 30, 2020	20-F	2021-10-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.